<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Coleção:</title>
    <link>http://repositorio.ufc.br/handle/riufc/41717</link>
    <description />
    <pubDate>Sat, 11 Apr 2026 11:08:52 GMT</pubDate>
    <dc:date>2026-04-11T11:08:52Z</dc:date>
    <item>
      <title>Antinociceptive Effect of the Monoterpene R-()-Limonene in Mice</title>
      <link>http://repositorio.ufc.br/handle/riufc/82680</link>
      <description>Título: Antinociceptive Effect of the Monoterpene R-()-Limonene in Mice
Autor(es): Amaral, Jeferson Falcão do; Silva, Maria Izabel Gomes; Neto, Manuel Rufino de Aquino; Neto, Paulo Florentino Teixeira; Moura, Brinell Arcanjo; Melo, Carla Thiciane Vasconcelos de; Araújo, Fernando Luiz Oliveira de; Sousa, Damião Pergentino de; Vasconcelos, Patrícia Freire de; Vasconcelos, Silvânia Maria Mendes de; Sousa, Francisca Cléa Florenço de
Abstract: In the present study were studied the antinociceptives properties of monoterpene R-()-limonene (LM) in&#xD;
chemical and thermal models of nociception in mice. The R-()-limonene was administered, intraperitoneally(i.p.), at doses of 25 and 50 mg/kg. The results showed significant inhibition produced on chemical nociception induced by intraperitoneal acetic-acid and in the second phase of subplantar formalin test, but did not manifest a significant effect in hot-plate test. The R-()-limonene-induced antinociception in second phase of formalin test was insensitive to naloxone (1 mg/kg, s.c.). It was also demonstrated that R-()-limonene (25, 50 mg/kg) neither significantly enhanced the pentobarbital-sleeping time nor impaired the motor performance in rota-rod test, indicating that the observed antinociception is unlikely to be due to sedation or motor abnormality. In conclusion it may be suggested that the R-()-limonene presented antinociceptive activity and that, probably, this action can&#xD;
be related with peripheral analgesia, but, not with the stimulation of opioids receptors.
Tipo: Artigo de Periódico</description>
      <pubDate>Mon, 01 Jan 2007 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/82680</guid>
      <dc:date>2007-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Polimorfismo do gene do receptor de progesterona (PROGINS) em mulheres  com câncer de mama. Estudo caso-controle</title>
      <link>http://repositorio.ufc.br/handle/riufc/82678</link>
      <description>Título: Polimorfismo do gene do receptor de progesterona (PROGINS) em mulheres  com câncer de mama. Estudo caso-controle
Autor(es): Linhares, José Juvenal; Silva, Ismael Dale Cotrim Guerreiro da; Souza, Naiara Correa Nogueira de; Noronha, Emmanuelle Coelho; Ferraro, Odair; Baracat, Fausto Farah
Abstract: to analyze the correlation between PROGINS polymorphism and breast cancer. Methods: a case-control study was carried out from April to October 2004. The genotypes of 50 women with breast cancer and 49 healthy women were analyzed. The 306-base pair Alu insertion polymorphism in the G intron of progesterone receptor gene was detected by polymerase chain reaction and analyzed on 2% agarose gel stained with ethidium bromide. The control and experimental groups were compared regarding genotypes using the statistical Epi-Info 6.0 program and for frequencies the exact Fisher test or χ2 test were used. p value smaller p than 5% was considered to be significant. Results: in relation to PROGINS we found in the&#xD;
studied population a prevalence of 62 (62.6%) wild homozygous, 35 (35.3%) heterozygous individuals and two (2.1%) cases with the presence of the mutation. Regarding PROGINS polymorphism, significance was not evidenced when cases and controls were compared, as related to homozygosis (62 vs 65.3%), heterozygosis (36 vs 34,6%) or the mutation (2.0 vs 2.1%), with p=0.920 (OR=1.01), 0.891 (OR=1.06), and 0.988 (OR=1.10), respectively. Conclusions: the results show that single-gene PROGINS polymorphism does not confer a substantial risk of breast cancer to its carriers.
Tipo: Artigo de Periódico</description>
      <pubDate>Sat, 01 Jan 2005 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/82678</guid>
      <dc:date>2005-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Genetic polymorphism of GSTM1 in women with breast cancer and interact with reproductive history and several clinical pathologies</title>
      <link>http://repositorio.ufc.br/handle/riufc/80679</link>
      <description>Título: Genetic polymorphism of GSTM1 in women with breast cancer and interact with reproductive history and several clinical pathologies
Autor(es): Linhares, José Juvenal; Silva, Ismael Dale Cotrim Guerreiro da; Souza, Naiara C. Nogueira de; Noronha, Emmanuelle Coelho; Ferraro, Odair; Carvalho, Cristina Valleta de; Baracat, Edmund Chada; Baracat, Fausto Farah
Abstract: Due to the conflicting results regarding the association between breast cancer and the GSTM1 null mutation,&#xD;
our aim was to research this association in a Brazilian population and correlations with smoking, reproductive&#xD;
history and several clinical pathologies. A case-control study was performed on 105 women with breast&#xD;
cancer and 278 controls. Extraction of DNA was accomplished according to the protocol of the GFX® kit and&#xD;
polymorphism analysis by the PCR technique. The control and experimental groups were compared and&#xD;
statistical analysis assessed by X2 or Fisher’s exact test. The deletion in the GSTM1 gene in the breast cancer&#xD;
group had a prevalence of 32 (30.4%) individuals with the presence of null mutation. In the control group, the&#xD;
null mutation was present in 104 (37.4%) women. Upon comparison of the two groups, no statistically&#xD;
significant difference of the GSTM1 gene was observed, with an odds ratio (OR) of 0.74, 95%, confidence&#xD;
interval (CI) 0.45 - 1.20, p = 0.277. The results conclusively show that single gene GSTM1 polymorphisms do&#xD;
not confer a substantial risk of breast cancer to its carriers. Furthermore, in this study no correlation was&#xD;
found between GSTs and smoking, reproductive history and several clinical pathologies with respect to cancer&#xD;
risk.
Tipo: Artigo de Periódico</description>
      <pubDate>Sat, 01 Jan 2005 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/80679</guid>
      <dc:date>2005-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Uso de células de linhagem TIGEF para cultivo e produção de  lentivírus ovino</title>
      <link>http://repositorio.ufc.br/handle/riufc/80006</link>
      <description>Título: Uso de células de linhagem TIGEF para cultivo e produção de  lentivírus ovino
Autor(es): Virgínio, Camila Gomes; Teixeira, Maria Fátima da Silva
Abstract: This article presents a review of cell culture concerning diagnostic virology and its use for ovine lentivirus&#xD;
diagnosis, through the improvement caused due to the introduction of a cell line named TIGEF, considered an advance for better study of the biological and molecular characteristics of ovine lentivirus infection.
Tipo: Artigo de Periódico</description>
      <pubDate>Thu, 01 Jan 2004 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/80006</guid>
      <dc:date>2004-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

